ACMD public event: open meeting on 12 June 2014

Advisory Council on the Misuse of Drugs

June 5
16:25 2014

The Advisory Council on the Misuse of Drugs invites members of the public to its Diversion and Illicit Supply of Medicines Inquiry open meeting on Thursday 12 June 2014.

Inquiry members on the ACMD will consider both oral and written evidence from important stakeholders. There will be an opportunity for attendees to provide feedback to the ACMD and participate in a question and answer session at the end of the meeting.

The scope of this review will include whether diversion and illicit supply of medicines displaces or replaces the misuse of known drugs of abuse, the prevalence of misuse of medicines obtained through these means, demographic of users, and the most prevalent drugs being misused in this manner.

Attending the meeting

The meeting will be held at the address below, starting at 10:30pm and ending at 4:30pm.

Double Tree Hotel
2 Bridge Place

The agenda will be made available at the meeting.

Attendance is free, but by registration only, as places are limited. Places will be issued on a first-come, first-served basis. To register to attend, please complete the registration form and email it to the ACMD Secretariat.

Alternatively, contact the ACMD Secretariat at:

ACMD Secretariat
2nd floor (NW quarter)
Seacole building
2 Marsham Street

Tel: 020 7035 0454


The ACMD is a statutory and non-executive non-departmental public body, established by the Misuse of Drugs Act 1971. The ACMD has a statutory duty to keep under review the situation in the United Kingdom with respect to the misuse of drugs and to advise ministers of the measures which they consider should to be taken to deal with social problems which arise from drug misuse.

In addition, the ACMD has a duty to consider any matter relating to drug dependence or misuse that may be referred to them by ministers. The Home Secretary is obliged by law to consult the ACMD before laying orders or making regulations.

Related Articles


  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:

Post my comment

Recent Comments

Follow Us on Twitter

Share This

Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: